期刊文献+

超声造影定量分析在宫颈癌化疗疗效评估中的应用 被引量:11

Application of Contrast-enhanced Ultrasound Quantitive Analysis in Assessing Efficacy of Chemotherapy in Cervical Cancer
原文传递
导出
摘要 [目的]探讨超声造影时间—强度曲线(TIC)在评估宫颈癌新辅助化疗疗效中的价值。[方法 ]对40例行新辅助化疗宫颈癌患者于化疗前和化疗2个疗程后采用超声造影和磁共振成像(magnetic resonance imaging,MRI)检查测量肿物最大径,以病理结果为金标准比较两种影像学方法测量的精确性。观察造影剂灌注情况,应用时间—强度曲线分析病变造影剂的到达时间(AT)、达峰时间(TTP)以及峰值强度(PI),比较化疗前后各参数的变化。[结果]1超声造影与MRI测量精确性未见明显差异(P>0.05)。2化疗有效组32例患者肿物明显缩小,TIC显示TTP较化疗前明显延长(P<0.05),PI下降(P<0.05);化疗无效组8例患者肿物缩小不明显,TTP与化疗前比较未见明显变化(P>0.05),PI有所增高,但无统计学差异(P>0.05)。两组患者的AT均较化疗前延长,但无统计学差异(P>0.05)。[结论]超声造影可作为肿物测量方法之一,时间—强度曲线参数可客观反映化疗前后宫颈肿物的血流灌注变化情况,有助于新辅助化疗效评估。 [Purpose] To investigate the value of time-intensity curves(TIC) of contrast-enhanced ultrasound(CEUS) in assessing the efficacy of neoadjuvant chemotherapy(NACT) for cervical cancer. [ Methods ] CEUS and magnetic resonance imaging (MRI) were performed before and after two courses of NACT in 40 patients with cervical cancer. Maximum diameters of the tumors were mea- sured ,and data obtained by both imaging methods were compared with pathological result as the gold standard. The accuracy of CEUS and MRI was compared. The perfusion mode of the lesions was observed, and the time -intensity curve (TIC) to get arriving time (AT), time to pick (TYP) and peak intensity(PI) of contrast agent were analyzed. The difference of TIC parameters before and af- ter NACT was compared. [ Results ] ① No significant difference was found between the measure- ment results of two imaging methods(P〉0.05). ② There are 32 cases with response to chemothera- py,which volume dramatically decreased, TTP of lesions dramatically prolonged (P〈0.05), PI de- creased (P 〈0.05) compared with before chemotherapy. Eight cases without response to chemotherapy,which volume did not change significantly,TFP of lesions did not change signifi- cantly (P〉0.05), PI increased with no significant difference(P〉0.05) after chemotherapy; while AT prolonged compared with before NACT,but no significantly difference (P〉0.05). [Conclusion] CEUS can be used as a method to measure the lesion of cervical cancer,TIC parameters can ob- jectively reflect the perfusion mode changes of the lesion before and after NACT,which benefit for assesing the response of NACT.
出处 《中国肿瘤》 CAS 2015年第5期435-438,共4页 China Cancer
关键词 超声造影 时间—强度曲线 宫颈肿瘤 新辅助化疗 contrast-enhanced ultrasound time-intensity cervical cancer neoadjuvant chemotherapy
  • 相关文献

参考文献8

  • 1余辉,吴楠.早期宫颈癌术前新辅助化疗研究进展[J].医学综述,2014,20(4):645-649. 被引量:3
  • 2Eisenhauer EA,Therasse P,Bogaerls J,el al. New re- sponse evaluation criteria in solid tumors:revised RECIST guideline (version 1.1)[J]. Eur J Cancer, 2009,45(2) : 228-247.
  • 3He L,Wu L,Su G,et al. The efficacy of neoadjuvant ehemotherapy in different histological types of cervical cancer [J]. Gynecol Oncol, 2014,134(2) :419-425.
  • 4Li R,Lu ST,Si JG,et al. Prognostic value of responsive- ness of neoadjuvant chemotherapy before surgery for pa- tients with stage I B2/II A2 cervical cancer [J].Gynecol Oncol, 2013,128(3) : 524-529.
  • 5Lassau N,Chami L,Benatsou B,et al. Dynamic contrast- enhanced uhrasonography (I)CE-US) with quantification of tumor perfusion :a new diagnostic tool to evaluate the early effects of antiangiogenic treatment[J]. Eur Radiol, 2007,17 (Suppl 6) : F89-F98.
  • 6De Giorgi U,Aliberti C,Benea G,et al. Effect of an- giosonography to monitor response during imalinib treat- ment in patients with metastatic gastrointestinal sit, mini tu- mors[J]. Clin Cancer Res, 2005,11 (17) : 6171-6176.
  • 7Greis C.Technical aspects of contrast-enhanced ultrasound (CEUS) examinations:tips and tricks [J]. Clin Hemorheol Microcirc ,2014,58(1):89-95.
  • 8张新玲,贺需旗,毛永江,黄泽萍,郑荣琴.超声造影评估宫颈癌化疗疗效[J].中国医学影像技术,2013,29(6):998-1001. 被引量:11

二级参考文献11

  • 1Shoji T, Kumagai S, Yoshizaki A, et al. Efficacy of neoadjuvantchemotherapy followed by radical hysterectomy in locally ad-vanced non-squamous carcinoma of the uterine cervix: A retro-spective multicenter study of Tohoku Gynecologic Cancer Unit.Eur J Gynaecol Oncol, 2012, 33(4) : 353*357.
  • 2Maneo A, Chiari S, Bonazzi C, et al. Neoadjuvant chemotherapyand conservative surgery for stage IB1 cervical Cancer. GynecolOncol, 2008,111(3):438-443.
  • 3Lassau N, Chami L, Benatsou B, et al. Dynamic contrast-en-hanced ultrasonography (DCE-US) with quantification of tumorperfusion: A new diagnostic tool to evaluate the early effects ofantiangiogenic treatment. Eur Radiol, 2007,17 ( Suppl 6) : F89-F98.
  • 4Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cer-vix uteri. FIGO 26th Annual Report on the Results of Treatmentin Gynecological Cancer. Int J Gynecol Obstet, 2006,95 (Suppl1):S43-S103.
  • 5Angioli R, Plotti F, Montera R, et al. Neoadjuvant chemothera-py plus radical surgery followed by chemotherapy in locally ad-vanced cervical Cancer. Gynecol Oncol, 2012, 127(2) :290-296.
  • 6De Giorgi U, Aliberti C, Benea G, et al. Effect of angio.sonogra-phy to monitor response during imatinib treatment in patientswith metastatic gastrointestinal stromal tumors. Clin Cancer Res,2005,11(17):6171-6176.
  • 7Foster FS, Burns PN, Simpson DH, et al. Ultrasound for the vi-sualization and quantification of tumor microcirculation. CancerMetastasis Rev, 2000, 19(.1-2) : 131-138.
  • 8Piscaglia F, Nolse C, Dietrich CF, et al. The EFSUMB guide-lines and recommendations on the clinical practice of contrast en-hanced ultrasound (CEUS) : Update 2011 on non-hepatic applica-tions. Ultraschall Med, 2012, 33( 1) : 33-59.
  • 9Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the useof contrast agents in ultrasound. January 2004. UltraschallMed, 2004,25(4):249-256.
  • 10印明柱,娄阁,陈秀玮,顾泰华.新辅助化疗后根治性手术与同步放化疗在局部晚期宫颈癌的远期疗效评价[J].实用肿瘤学杂志,2011,25(1):40-45. 被引量:42

共引文献12

同被引文献76

引证文献11

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部